1 tracked 13F filer discloses a position in RPTX as of the latest SEC 13F filings, a combined $310K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Militia Capital Partners, LP | $310K | 119K | —Held | Q4 2025 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 38 funds | $16.7B |
| T-MOBILE US INCTMUS | 38 funds | $9.9B |
| VISA INC-CLASS A SHARESV | 37 funds | $45.8B |
| BRISTOL-MYERS SQUIBB COBMY | 37 funds | $18.7B |
| PFIZER INCPFE | 37 funds | $17.3B |
| BOSTON SCIENTIFIC CORPBSX | 37 funds | $8.0B |
| THE CIGNA GROUPCI | 37 funds | $7.9B |
| MICROSOFT CORPMSFT | 36 funds | $173.3B |
| AMAZON.COM INCAMZN | 36 funds | $131.4B |
| META PLATFORMS INC-CLASS AMETA | 36 funds | $61.1B |
| ALPHABET INC-CL CGOOG | 36 funds | $55.0B |
| HOME DEPOT INCHD | 36 funds | $35.5B |
Ranked by how many of RPTX's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Mar 12, 2025 | Segal Lloyd Mitchell | PRESIDENT AND CEO, Director | Sell (S) | 21K | $24K |
| Mar 12, 2025 | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | Sell (S) | 7K | $8K |
| Mar 12, 2025 | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | Sell (S) | 6K | $6K |
| Mar 12, 2025 | Koehler Maria | EVP, CHIEF MEDICAL OFFICER | Sell (S) | 4K | $4K |
| Apr 1, 2024 | Koehler Maria | EVP, CHIEF MEDICAL OFFICER | Sell (S) | 300 | $1K |
| Apr 1, 2024 | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | Sell (S) | 410 | $2K |
| Apr 1, 2024 | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | Sell (S) | 789 | $4K |
| Apr 1, 2024 | Segal Lloyd Mitchell | PRESIDENT AND CEO, Director | Sell (S) | 2K | $12K |
| Mar 28, 2024 | Koehler Maria | EVP, CHIEF MEDICAL OFFICER | Sell (S) | 500 | $2K |
| Mar 28, 2024 | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | Sell (S) | 450 | $2K |
| Mar 28, 2024 | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | Sell (S) | 825 | $4K |
| Mar 28, 2024 | Segal Lloyd Mitchell | PRESIDENT AND CEO, Director | Sell (S) | 3K | $12K |
Connected entities for RPTX
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/RPTX/capital-change-brief"
Use Arkolith's capital_change_brief for RPTX. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for RPTX. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.